These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19623671)

  • 21. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
    Martin SI; Zukerberg L; Robbins GK
    Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
    Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [EBV quantification in children after allogeneic hematopoietic stem cell transplantation].
    Hubácek P; Cinek O; Kulich M; Zajac M; Keslová P; Formánková R; Starý J; Sedlácek P
    Cas Lek Cesk; 2006; 145(4):301-6. PubMed ID: 16639931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
    Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Epstein-Barr virus in lymphoproliferative diseases of the lung.
    Shimakage M; Sakamoto H; Harada S; Sasagawa T; Kodama K
    Oncol Rep; 2007 Jun; 17(6):1347-52. PubMed ID: 17487389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chorioretinal lymphoproliferative disorder induced by Epstein-Barr virus in lung transplantation].
    Demols P; Caspers-Velu L; Velu T; Verougstraete C; Zanen A
    Bull Soc Belge Ophtalmol; 1995; 259():109-13. PubMed ID: 8983528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
    Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
    Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation.
    Sirvent N; Reviron D; de Lamballerie X; Michel G
    Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028
    [No Abstract]   [Full Text] [Related]  

  • 31. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.
    Oyama T; Yamamoto K; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Takeuchi K; Izumo T; Mori S; Ohshima K; Suzumiya J; Nakamura N; Abe M; Ichimura K; Sato Y; Yoshino T; Naoe T; Shimoyama Y; Kamiya Y; Kinoshita T; Nakamura S
    Clin Cancer Res; 2007 Sep; 13(17):5124-32. PubMed ID: 17785567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epstein-Barr virus and post-transplantation lymphoproliferations].
    Leblond V
    Ann Med Interne (Paris); 1997; 148(5):376-8. PubMed ID: 9538412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome.
    Ho AY; Adams S; Shaikh H; Pagliuca A; Devereux S; Mufti GJ
    Bone Marrow Transplant; 2002 May; 29(10):867-9. PubMed ID: 12058237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).
    Holtan SG; Porrata LF; Colgan JP; Zent CS; Habermann TM; Markovic SN
    Am J Hematol; 2008 Aug; 83(8):688-9. PubMed ID: 18528858
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China.
    Dilmurat D; Wang X; Gao L; Tian J; Ai J; Zhang L; Liu M; Feng G; Zeng Y; Wang R; Xie Z
    Ital J Pediatr; 2024 Jul; 50(1):125. PubMed ID: 38956696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of PTLD following renal transplantation in a child.
    Markert E; Siebolts U; Habbig S; Odenthal M; Dienes HP; Stippel DL; Hoppe B; Wickenhauser C
    Pediatr Transplant; 2009 May; 13(3):379-83. PubMed ID: 19017284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-transplant lymphoproliferative disorder limited to the skin.
    Samolitis NJ; Bharadwaj JS; Weis JR; Harris RM
    J Cutan Pathol; 2004 Jul; 31(6):453-7. PubMed ID: 15186434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
    Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.